Cargando…
To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus
The prevalence of diabetes mellitus (DM) is increasing at a staggering rate around the world. In the United States, more than 30.3 million Americans have DM. Type 2 diabetes mellitus (T2DM) accounts for 91.2% of diabetic cases and disproportionately affects African Americans and Hispanics. T2DM is a...
Autores principales: | Fluitt, Maurice B., Mohit, Neal, Gambhir, Kanwal K., Nunlee-Bland, Gail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885279/ https://www.ncbi.nlm.nih.gov/pubmed/35237694 http://dx.doi.org/10.1155/2022/5126968 |
Ejemplares similares
-
MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus
por: Yang, Xiyao, et al.
Publicado: (2022) -
Diabetic Cheiroarthropathy: A Case Report and Review of the Literature
por: Cherqaoui, Rabia, et al.
Publicado: (2013) -
Case Study: Use of GLP-1 Receptor Agonist in a Patient on Intensive Insulin Therapy
por: Wiley, Kenneth Calvin, et al.
Publicado: (2015) -
Exosomal microRNAs as tumor markers in epithelial ovarian cancer
por: Pan, Chi, et al.
Publicado: (2018) -
MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction
por: Silambarasan, Maskomani, et al.
Publicado: (2016)